Five patent families, three technical layers
A metabolically orthogonal chassis, an optogenetic septal pore valve, and a scaffold geometry built for hyphal growth. Covered by US provisional application 64/087,071, filed June 10, 2026.
Layer 1 — Chassis
Metabolically Orthogonal N. crassa
The iJDZ836 genome-scale metabolic model (836 genes, ~1,200 reactions) describes a metabolically capable organism. Flux-balance analysis confirms xylose as a preferred carbon source and the valid chassis feed for the chow reservoir.
The carbon source screen found 24 of 78 tested sources support growth. Gene essentiality analysis flagged ~130 of 836 genes (~15.5%) as essential — the hard boundary for knockout targeting.
We screened 10,440 double-knockout pairs from a 145-gene pool of transporter and central carbon genes, ranking each by Composite Orthogonality Score. Sixteen strains clear the chip-integration threshold (RBS ≥ 0.868) — the recommended chassis candidates.
Orthogonality is strong but partial, and we state it that way deliberately.
The leading chassis blocks roughly 87% of reagent uptake while sustaining xylose growth at approximately 18–19% of wild-type rate. The tradeoff between blocking and fitness is a design constraint, not a defect: the chip-integration threshold is set where enough residual growth remains for robust colonization.
Phenotype Tiers
| Tier | Ranks | Characteristics |
|---|---|---|
| 1 — Best | 1–16 | Best sugar blocking, ~18–19% WT xylose growth |
| 2 — Balanced | 17–32 | More aggressive blocking, marginal xylose |
| 3 — Fitness | 33–50 | Best xylose fitness, weaker sugar blocking |
Model
iJDZ836
KO Pairs Screened
10,440
Chip-Eligible Strains
16
Metabolic Orthogonality
IP Coverage
The pore array already exists in the organism. The actuator adds an anchor at the rim and a light-gated plug — nothing has to be fabricated into the channel.
This diagram shows the intended mechanism, not a measured result. Stage 1 is established N. crassa biology. Stages 2 and 3 are the behavior our constructs are designed to produce; whether they do is precisely what Gates 1 and 2 determine.
Layer 2 — Valve
Optogenetic Septal Pore Valve
Hyphae of N. crassa are partitioned by septa, each perforated by a central pore roughly 150 nm across, natively gated by Woronin bodies built from the self-assembling protein HEX1. The organism has already fabricated a dense valve array — it is simply not addressable.
Our two-component actuator makes it addressable. CompA_v3 fuses the Avena sativa LOV2 photosensor, through its Jα helix, to HEX1. CompB anchors an ePDZ domain at the pore via SPA1. Blue light at 450 nm undocks Jα, exposes the binding motif, and drives recruitment and oligomerization at the anchored site. Removing light reverses it — fail-safe open logic, since no light means no plug.
Component A — LOV2-HEX1 Plug
LOV2 + Jα — blue-light photosensor from Avena sativa phototropin 1. Uses ubiquitous FMN as its chromophore — no foreign cofactor required. N-terminal placement keeps the HEX1 self-assembly contacts free. pLDDT = 91 (ColabFold).
HEX1 core (150 aa) — N. crassa Woronin-body protein, naturally evolved to plug septal pores under stress. Fused C-terminal via a (GGGGS)×3 linker; freely cytoplasmic until light-tethered. pLDDT = 88.
Component B — SPA1-ePDZ Anchor
SPA1 (aa 1–146) — N. crassa septal-pore-rim localizing domain. Constitutively anchored at the pore rim; no light dependence in localization.
ePDZ (engineered PDZ, iLID system) — light-gated affinity switch: ~130 nM in the lit state (Jα exposed) vs. >10 µM dark (Jα docked, epitope hidden). pLDDT = 88.
Thermal reversion: LOV2 dark recovery (seconds–minutes) automatically reopens the valve without any input signal. True fail-safe open behavior.
What is established and what is not
Both constructs are designed, codon-optimized, and modeled. Per-domain structure confidence is high (pLDDT 91 for LOV2, 88 for HEX1).
Interface confidence is not. Our construct presents the binding motif through an internal linker rather than at a free C-terminus, departing from canonical PDZ geometry, and multimer prediction of the lit-state complex returned an inconclusive ipTM of 0.18. Two measurements resolve this — SEC-MALS and BLI — and they are the next work we do.
Valve Mechanism
≥10×
Dark/lit contrast — Gate 2 criterion
450 nm
Activation wavelength
IP Coverage
Layer 3 — Scaffold
H-Tree Scaffold & Integration
The H-tree topology is the critical design choice. Every one of the 16 terminal reagent ports is exactly the same path length from the central chow reservoir — ensuring simultaneous, pressure-balanced reagent delivery.
Channel Sizing Rationale
| Level | Width | Hyphae | Function |
|---|---|---|---|
| Root–L1 | 20 µm | 4–8 | Main trunk — flow redundancy |
| L2–L3 | 13–17 µm | 2–3 | Valve control zone |
| Depth (all) | 15 µm | — | Matches hyphal diameter |
Chip Size
10×10 mm
Ports
16 reagent + 1 chow
Levels
4 branching levels
Compatibility
SU-8 / PDMS / Print
IP Coverage
H-Tree scaffold — 10×10 mm, 4 levels, 16 ports · channel width 13–20 µm, set against measured N. crassa hyphal geometry rather than adapted from PDMS conventions
Five patent families — US provisional 64/087,071, filed June 10, 2026
Michael McKenna is sole applicant. The application is owned outright, with no institutional encumbrance.
| # | Family | Description | Strength |
|---|---|---|---|
| 01 | Metabolically orthogonal chassis | Specific genotype + six-gene KO screening method | HIGH |
| 02 | Optogenetic septal pore valve | LOV2-Jα-HEX1 + SPA1-ePDZ constructs & flow control method | HIGH |
| 03 | Living microfluidic device | Chip + organism + scaffold as integrated system | HIGH |
| 04 | H-tree scaffold, fungal dimensions | Fungal-specific channel geometry (13–20 µm) novel over PDMS art | MED |
| 05 | Six-gene chassis (Δcre-1 + Δwc-1) | Requirement for 450 nm optogenetic activation in orthogonal host | HIGH |